Oral Hypoglycemic Drugs

CASE DISCUSSION

Oral Hypoglycemic Drugs

India flagPresented from India by Dr. Varsha Kachroo

0

Likes

2027

Views

81

Shares

101

Bookmarks

Case Description

The most effective management of diabetes mellitus demands an interprofessional approach involving both lifestyle modifications with diet and exercise and pharmacologic therapies as necessary to meet individualized glycemic goals. Lifestyle modifications must be combined with oral pharmacologic...

Case Summary

  • The webinar focused on oral anti-diabetic drugs (OADs), now referred to as oral anti-hyperglycemic drugs due to their lower risk of hypoglycemia. The discussion included an overview of OADs, their mechanisms of action, side effects, contraindications, and strategies for improving patient outcomes.

Speaker Profile

Dr. Varsha Kachroo

Dr. Varsha Kachroo

Consultant Endocrinology, Yatharth Super Speciality Hospitals, Delhi

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Assimilate | Oral Hypoglycemic Drugs